Rheumatoid Arthritis and Adipokines

Kürşat Oğuz Yaykaşlı 1 *
More Detail
1 Düzce Üniversitesi, Tıp Fakültesi, Tıbbi Genetik AD, Düzce, Türkiye
* Corresponding Author
EUR J BASIC MED SCI, Volume 3, Issue 2, pp. 38-43. https://doi.org/10.21601/ejbms/9200
OPEN ACCESS
Download Full Text (PDF)

ABSTRACT

Rheumatoid arthritis (RA) is inflammatory, auto-immune and multifaktariyel disease. Although the etiology of RA is unkown in detail, the destruction of articular cartilage tissue caused by elevated aggrecanase activitiy with inflammation is known to be crucial event in the early stages of RA. The adippokines secreted by several tissues especially adipose tissue are inflammatory cytokines. There are several investigations have been reported that the levels of adipokines changed in patients with RA. In this study the researches on the possible relationship between adipokines and RA have been reviewed.
Keywords: rheumatoid arthritis, adipokines, inflammation

CITATION

Yaykaşlı KO. Rheumatoid Arthritis and Adipokines. Eur J Basic Med Sci. 2013;3(2):38-43. https://doi.org/10.21601/ejbms/9200

REFERENCES

  • Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci 2006; 11: 529-43.
  • Sayarlıoğlu M, İzmirli M, Uzun K, Alıcı S, Erkoç R. Rheumatoid arthritis and pulmonary carcinoid tumor. Eur J Gen Med 2005; 2(1): 35-38.
  • Yazici S, Bulur S, Sözen SB, Çalık Y, Baki AE, Önder E, Özhan H, Yazıcı M, Ataoğlu S. Evaluation of Lipid Parameters in Patients with Rheumatoid Arthritis. Konuralp Tıp Dergisi [Konuralp Medical Journal] 2009; 1(1): 2-6.
  • Schaeverbeke T, Truchetet MÉ, Richez C. When and where does rheumatoid arthritis begin? Joint Bone Spine 2012; 79(6): 550-4.
  • Little CB, Meeker CT, Golub SB, Lawlor KE, Farmer PJ, Smith SM, Fosang AJ. Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair. J Clin Invest 2007; 117(6): 1627-36.
  • Knevel R, Tsonaka R, le Cessie S, van der Linden MP, Huizinga TW, van der Heijde DM, Houwing-Duistermaat JJ, van der Helm-van Mil AH. Comparison of methodologies for analysing the progression of joint destruction in rheumatoid arthritis. Scand J Rheumatol 2013; 42(3): 182-9.
  • Poole CA. Articular cartilage chondrons: form, function and failure. J Anat. 1997; 191 (Pt 1):1-13.
  • Koshy PJ, Lundy CJ, Rowan AD, Porter S, Edwards DR, Hogan A, Clark IM, Cawston TE. The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction. Arthritis Rheum 2002; 46(4): 961-7.
  • Dudhia J. Aggrecan, aging and assembly in articular cartilage. Cell Mol Life Sci 2005; 62(19-20): 2241-56.
  • Doi H, Nishida K, Yorimitsu M, Komiyama T, Kadota Y, Tetsunaga T, Yoshida A, Kubota S, Takigawa M, Ozaki T. Interleukin-4 downregulates the cyclic tensile stress-induced matrix metalloproteinases-13 and cathepsin B expression by rat normal chondrocytes. Acta Med Okayama 2008; 62(2): 119-26.
  • Yaykasli KO, Oohashi T, Hirohata S, Hatipoglu OF, Inagawa K, Demircan K, Ninomiya Y. ADAMTS9 activation by interleukin 1 beta via NFATc1 in OUMS-27 chondrosarcoma cells and in human chondrocytes. Mol Cell Biochem 2009; 323(1-2): 69-79.
  • Pfeil A, Oelzner P, Bornholdt K, Hansch A, Lehmann G, Renz DM, Wolf G, Bottcher J. Joint damage in rheumatoid arthritis: assessment of a new scoring method. Arthritis Res Ther 2013; 15(1): R27.
  • Fosang AJ, Little CB. Drug insight: aggrecanases as therapeutic targets for osteoarthritis. Nat Clin Pract Rheumatol 2008; 4(8): 420-7.
  • You S, Cho CS, Lee I, Hood L, Hwang D, Kim WU. A systems approach to rheumatoid arthritis. PLoS One 2012; 7(12): e51508.
  • Conde J, Scotece M, López V, Gómez R, Lago F, Pino J, Gómez-Reino JJ, Gualillo O. Adipokines: novel players in rheumatic diseases. Discov Med 2013; 15(81): 73-83.
  • Scotece M, Conde J, Gómez R, López V, Lago F, Gómez- Reino JJ, Gualillo O. Beyond fat mass: exploring the role of adipokines in rheumatic diseases. Scientific World Journal 2011; 11: 1932-47.
  • Altunkaynak BZB, Özbek E. Yağ dokusu endokrin bir organ mıdır? Dicle Tıp Dergisi 2005; 32(4): 211-217.
  • Wozniak SE, Gee LL, Wachtel MS, Frezza EE. Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 2009; 54(9): 1847-56.
  • Gabay O, Berenbaum F. Adipokines in Arthritis: New Kids on the Block. Current Rheumatology Reviews 2009; 5: 226-32.
  • Vergunst CE, van de Sande MG, Lebre MC, Tak PP. The role of chemokines in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 2005; 34(6): 415-25.
  • Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 372(6505): 425-32.
  • Hekimoğlu A. Leptin ve fizyopatolojik olaylardaki rolü, Dicle Tıp Dergisi 2006; 33(4): 259-67.
  • Scotece M, Conde J, López V, Lago F, Pino J, Gómez-Reino JJ, Gualillo O. Leptin in Joint and Bone Diseases: New Insights. Curr Med Chem 2013; 20(27): 3416-25.
  • Wisłowska M, Rok M, Jaszczyk B, Stepień K, Cicha M. Serum leptin in rheumatoid arthritis. Rheumatol Int 2007; 27(10): 947-54.
  • Bao JP, Chen WP, Feng J, Hu PF, Shi ZL, Wu LD. Leptin plays a catabolic role on articular cartilage. Mol Biol Rep 2010; 37(7): 3265-72.
  • Tong KM, Shieh DC, Chen CP, Tzeng CY, Wang SP, Huang KC, Chiu YC, Fong YC, Tang CH. Leptin induces IL-8 expression via leptin receptor, IRS-1, PI3K, Akt cascade and promotion of NF-kappaB/p300 binding in human synovial fibroblasts. Cell Signal 2008; 20(8): 1478-88.
  • Muraoka S, Kusunoki N, Takahashi H, Tsuchiya K, Kawai S. Leptin stimulates interleukin-6 production via janus kinase 2/signal transducer and activator of transcription 3 in rheumatoid synovial fibroblasts. Clin Exp Rheumatol 2013; 31(4): 589-95.
  • Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996; 221(2): 286-9.
  • Garaulet M, Hernández-Morante JJ, de Heredia FP, Tébar FJ. Adiponectin, the controversial hormone. Public Health Nutr 2007; 10(10A): 1145-50.
  • Scotece M, Conde J, López V, Lago F, Pino J, Gómez-Reino JJ, Gualillo O. Adiponectin and Leptin: New Targets in Inflammation. Basic Clin Pharmacol Toxicol. 2013 Jul 8. doi: 10.1111/bcpt.12109. [Epub ahead of print]
  • Brochu-Gaudreau K, Rehfeldt C, Blouin R, Bordignon V, Murphy BD, Palin MF. Adiponectin action from head to toe. Endocrine 2010; 37(1): 11-32.
  • Toussirot É, Binda D, Gueugnon C, Dumoulin G. Adiponectin in autoimmüne diseases. Curr Med Chem 2012; 19(32): 5474-80.
  • Neumann E, Frommer KW, Vasile M, Müller-Ladner U. Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases? Arthritis Rheum 2011; 63(5): 1159-69.
  • Ebina K, Fukuhara A, Ando W, Hirao M, Koga T, Oshima K, Matsuda M, Maeda K, Nakamura T, Ochi T, Shimomura I, Yoshikawa H, Hashimoto J. Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction. Clin Rheumatol 2009; 28(4): 445-51.
  • Senolt L, Pavelka K, Housa D, Haluzík M. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine 2006; 35(5-6): 247-52.
  • Ozgen M, Koca SS, Dagli N, Balin M, Ustundag B, Isik A. Serum adiponectin and vaspin levels in rheumatoid arthritis. Arch Med Res 2010; 41(6): 457-63.
  • Schäffler A, Ehling A, Neumann E, Herfarth H, Tarner I, Schölmerich J, Müller-Ladner U, Gay S. Adipocytokines in synovial fluid. JAMA 2003; 290(13): 1709-10.
  • Ebina K, Fukuhara A, Ando W, Hirao M, Koga T, Oshima K, Matsuda M, Maeda K, Nakamura T, Ochi T, Shimomura I, Yoshikawa H, Hashimoto J. Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction. Clin Rheumatol 2009; 28(4): 445-51.
  • Ehling A, Schäffler A, Herfarth H, Tarner IH, Anders S, Distler O, Paul G, Distler J, Gay S, Schölmerich J, Neumann E, Müller-Ladner U. The potential of adiponectin in driving arthritis. J Immunol 2006; 176(7): 4468-78.
  • Kitahara K, Kusunoki N, Kakiuchi T, Suguro T, Kawai S. Adiponectin stimulates IL-8 production by rheumatoid synovial fibroblasts. Biochem Biophys Res Commun 2009; 378(2): 218-23.
  • Tang CH, Chiu YC, Tan TW, Yang RS, Fu WM. Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway. J Immunol 2007; 179(8): 5483-92.
  • Chen X, Lu J, Bao J, Guo J, Shi J, Wang Y. Adiponectin: a biomarker for rheumatoid arthritis? Cytokine Growth Factor Rev 2013; 24(1): 83-9.
  • Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature 2001; 409(6818): 307-12.
  • Stofkova A. Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity. Endocr Regul 2010; 44(1): 25-36.
  • Fadda SM, Gamal SM, Elsaid NY, Mohy AM. Resistin in inflammatory and degenerative rheumatologic diseases : Relationship between resistin and rheumatoid arthritis disease progression. Z Rheumatol 2013; 72(6): 594-600.
  • Gheita TA, El-Gazzar II, El Shazly RI, El-Din AM, Abdel-Rasheed E, Bassyouni RH. Gheita TA, El-Gazzar II, El Shazly RI, El-Din AM, Abdel-Rasheed E, Bassyouni RH. Elevated serum resistin in juvenile idiopathic arthritis: relation to categories and disease activity. J Clin Immunol 2013; 33(1): 297-301.
  • Senolt L, Housa D, Vernerová Z, Jirásek T, Svobodová R, Veigl D, Anderlová K, Müller-Ladner U, Pavelka K, Haluzík M. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis 2007; 66(4): 458-63.
  • Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 2003; 309(2): 286-90.
  • Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005; 174(9): 5789-95.
  • Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994; 14(2): 1431-7.
  • Stastny J, Bienertova-Vasku J, Vasku A. Visfatin and its role in obesity development. Diabetes Metab Syndr 2012; 6(2): 120-4.
  • Bao JP, Chen WP, Wu LD. Visfatin: a potential therapeutic target for rheumatoid arthritis. J Int Med Res 2009; 37(6): 1655-61.
  • Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T, Shintani A, Pincus T, Stein CM. Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum 2009; 60(7): 1906-14.
  • Senolt L, Kryštůfková O, Hulejová H, Kuklová M, Filková M, Cerezo LA, Běláček J, Haluzík M, Forejtová S, Gay S, Pavelka K, Vencovský J. The level of serum visfatin (PBEF) is associated with total number of B cells in patients with rheumatoid arthritis and decreases following B cell depletion therapy. Cytokine 2011; 55(1): 116-21.
  • Otero M, Lago R, Gomez R, Lago F, Dieguez C, Gómez-Reino JJ, Gualillo O. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 2006; 65(9): 1198-201.
  • El-Hini SH, Mohamed FI, Hassan AA, Ali F, Mahmoud A, Ibraheem HM. Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients. Rheumatol Int 2013; 33(9): 2283-9.
  • Gosset M, Berenbaum F, Salvat C, Sautet A, Pigenet A, Tahiri K, Jacques C. Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis. Arthritis Rheum 2008; 58(5): 1399-409.
  • Schäffler A, Neumeier M, Herfarth H, Fürst A, Schölmerich J, Büchler C. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 2005; 1732(1-3): 96-102.
  • Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, Shuldiner AR, Fried SK, McLenithan JC, Gong DW. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006; 290(6): E1253-61.
  • Krysiak R, Handzlik-Orlik G, Okopien B. The role of adipokines in connective tissue diseases. Eur J Nutr 2012; 51(5): 513-28.
  • de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman M, Fried SK, Gong DW, Shuldiner AR, Pollin TI, McLenithan JC. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007; 56(6): 1655-61.
  • Moreno-Navarrete JM, Catalán V, Ortega F, Gómez- Ambrosi J, Ricart W, Frühbeck G, Fernández-Real JM. Circulating omentin concentration increases after weight loss. Nutr Metab (Lond) 2010; 7:27.
  • Jialal I, Devaraj S, Kaur H, Adams-Huet B, Bremer AA. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab 2013; 98(3): E514-7.
  • Ismail SA, Mohamed SA. Serum levels of visfatin and omentin-1 in patients with psoriasis and their relation to disease severity. Br J Dermatol 2012; 167(2): 436-9.
  • Shibata R, Ouchi N, Kikuchi R, Takahashi R, Takeshita K, Kataoka Y, Ohashi K, Ikeda N, Kihara S, Murohara T. Circulating omentin is associated with coronary artery disease in men. Atherosclerosis 2011; 219(2): 811-4.
  • Zhong X, Zhang HY, Tan H, Zhou Y, Liu FL, Chen FQ, Shang DY. Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sin 2011; 32(7): 873-8.
  • Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, Hara Y. Omentin, a novel adipocytokine inhibits TNFinduced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun 2011; 408(2): 339-43.
  • Kazama K, Usui T, Okada M, Hara Y, Yamawaki H. Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells. Eur J Pharmacol 2012; 686(1-3): 116-23.
  • Zhong X, Li X, Liu F, Tan H, Shang D. Omentin inhibits TNF-α-induced expression of adhesion molecules in endothelial cells via ERK/NF-κB pathway. Biochem Biophys Res Commun 2012; 425(2): 401-6.
  • Senolt L, Polanská M, Filková M, Cerezo LA, Pavelka K, Gay S, Haluzík M, Vencovsky J. Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann Rheum Dis 2010; 69(7): 1410-1.
  • Xu L, Zhu GB, Wang L, Wang DF, Jiang XR. Synovial fluid omentin-1 levels are inversely correlated with radiographic severity of knee osteoarthritis. J Investig Med 2012; 60(3): 583-6.
  • Tan BK, Adya R, Randeva HS. Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc Med 2010; 20(5): 143-8.